Browse
Explore conditions, clinical trials, and the organisations running them.
Find a trial
Search by condition, then narrow by status and aim.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
137755 trials found · Page 1001 of 6888
-
Four-Drug combo aims to push High-Risk myeloma into deep remission
Disease control OngoingThis phase II trial studies the effect of selinexor when combined with carfilzomib, daratumumab, and dexamethasone in treating patients with high-risk multiple myeloma that has come back (recurrent) or has not responded to treatment (refractory) and who have received 1-3 prior li…
Phase 2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Could a blood pressure pill shield blood vessels from heart attacks?
Disease control OngoingANCA-associated vasculitis is an autoimmune disease that causes damage to blood vessels. This leads to organ damage with the number of organs affected and the severity of damage varying significantly between patients. Vasculitis patients also have a very high risk of heart attac…
Phase 2 • Sponsor: University of Edinburgh • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New shingles shot put to the test
Vaccine CompletedThe purposes of the study are to evaluate the safety and tolerability of different dose levels of recombinant herpes zoster vaccine (CHO Cells) with 2 doses at 2-month intervals in healthy subjects aged 18 years and older, and to preliminarily explore immunogenicity.
Phase 1 • Sponsor: MAXVAX Biotechnology Limited Liability Company • Aim: Vaccine
Last updated Oct 17, 2026 00:00 UTC
-
New drug Rina-S shows promise in battling Hard-to-Treat cancers
Disease control Recruiting nowThis study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors. Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be removed with surgery (unrese…
Phase 1/2 • Sponsor: Genmab • Aim: Disease control
Last updated Oct 09, 2026 00:00 UTC
-
HIV breakthrough? antibody cocktail aims to replace daily meds
Disease control CompletedThe proposed study is a phase 1, open label, single arm study to evaluate the safety and antiretroviral activity of the combination of two long-acting broadly neutralizing antibodies, 3BNC117-LS dosed once at 30 mg/kg and 10-1074-LS dosed once at 10 mg/kg, both intravenously (IV)…
Phase 1 • Sponsor: Rockefeller University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New heart procedure could free AF patients from daily pills
Disease control CompletedThe purpose of this study is to evaluate the long term off-Antiarrhythmic Drug (AAD) effectiveness of Biosense Webster, Inc. Irreversible Electroporation (BWI IRE) system in treatment of participants with symptomatic drug refractory paroxysmal atrial fibrillation (PAF).
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New combo therapy before surgery shows promise for rare skin cancer
Disease control OngoingThis is a window-of-opportunity study for patients with resectable Merkel Cell Carcinoma. The aim of this study is to test the activity of a course of chemo-immunotherapy followed by surgery in patients with operable Merkel cell carcinoma. Participants will receive one cycle of…
Phase 2 • Sponsor: Gruppo Oncologico del Nord-Ovest • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
A new scan aims to watch amyloid deposits in the body over time
Diagnosis CompletedThe goal of this research study is to determine whether changes in organ-specific uptake of 124I- AT-01 can be measured by PET/CT imaging and further, whether these values correlate with changes in a subject's disease status and thereby enable monitoring of disease response over …
Phase 2 • Sponsor: University of Tennessee Graduate School of Medicine • Aim: Diagnosis
Last updated Sep 04, 2026 00:00 UTC
-
One spot, many warts: heat and peroxide may trigger a full clearance
Disease control Recruiting nowHyperthermia treatment (hyperthermia) refers to treating diseases with temperature (39-45 ° C) beyond normal body temperature,. It has been reported that local warming at 44 ° C is able to effectively mobilize the body's immunity and clear HPV infected lesions, such as condyloma …
Sponsor: First Hospital of China Medical University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Triple-Drug attack shows promise against tough liver cancer
Disease control OngoingThis phase II trial compares the effect of adding bevacizumab and atezolizumab to gemcitabine and cisplatin (chemotherapy) versus chemotherapy and atezolizumab in treating patients with liver cancer that cannot be removed by surgery (unresectable) or that may have spread from whe…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Gene test may guide kidney cancer therapy choice
Disease control Recruiting nowThis phase II trial tests whether using genetic testing of tumor tissue to select the optimal treatment regimen works in treating patients with clear cell renal cell (kidney) cancer that has spread to other places in the body (advanced or metastatic). The current Food and Drug Ad…
Phase 2 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Biomarker-Guided combo aims to outsmart tough cancers
Disease control Recruiting nowThis phase II trial studies the good and bad effects of the combination of drugs called cabozantinib and nivolumab in treating patients with melanoma or squamous cell head and neck cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant p…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Oct 25, 2026 00:00 UTC
-
Can software help doctors spot a hidden inherited cholesterol threat?
Diagnosis OngoingA cluster randomized study in the primary care setting to evaluate a computer-based clinical decision support system to aid in the identification and management of patients with FH. The primary outcome of the study is the number of patients diagnosed with FH thirty-six months aft…
Sponsor: University Hospital, Linkoeping • Aim: Diagnosis
Last updated Oct 16, 2026 00:00 UTC
-
Can math make thyroid hormone therapy more precise?
Disease control CompletedThrough pharmacometric approaches-including modeling, mathematics, and statistics-this work aims to refine the levothyroxine sodium tablet (brand name: Euthyrox) dosing strategy in post-thyroidectomy cancer patients, enabling individualized precision dosing to minimize side effec…
Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New hope for Hard-to-Treat lung cancer: targeted pill shows promise
Disease control OngoingThis study aims to evaluate the antitumor activity and safety of JDQ443 single-agent as first-line treatment for participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors harbor a KRAS G12C mutation and have a PD-L1 expression \< 1% (cohort …
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Oct 10, 2026 00:00 UTC
-
New mammogram tech could spot hidden breast cancers in dense tissue
Diagnosis Recruiting nowTo learn whether a new imaging technology, Contrast-Enhanced Mammography (CEM), compared to standard mammography, can better detect breast cancers in women with dense breasts
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jul 18, 2026 00:00 UTC
-
New drug cocktail aims to wipe out breast cancer before surgery
Disease control OngoingAnlotinib is an oral multi-targeted tyrosine kinase inhibitor (TKI) that strongly inhibits VEGFR, PDGFR, FGFR, and c-kit. Combining anti-angiogenesis with chemotherapy yielded increased response rates in patients with early-stage human epidermal growth factor receptor 2 (HER2)-ne…
Phase 2 • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Immune cell levels may guide breast cancer treatment in new trial
Disease control OngoingThis study will assess if the presence of immune system cells in and around the tumor impacts tumor shrinkage in patients receiving neoadjuvant chemoimmunotherapy for triple-negative breast cancer.
Phase 2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New pill could quiet chronic cough that just Won't stop
Symptom relief OngoingThis is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 3 study of BLU-5937 in participants with Refractory Chronic Cough (RCC).
Phase 3 • Sponsor: Bellus Health Inc. - a GSK company • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Could a 66-cent pill replace CPAP for sleep apnea?
Disease control CompletedObstructive sleep apnea (OSA) is a severe type of snoring causing people to choke in their sleep. It affects millions of Americans, causing many health problems. For example, patients with OSA often feel very sleepy and are at risk of falling asleep while driving. OSA also causes…
Phase 2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC